ABVC BioPharma, Inc. (ABVC)
1.41
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Total Liabilities (Quarterly) : 6.904M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 45.49M |
| Perspective Therapeutics, Inc. | 63.33M |
| MiMedx Group, Inc. | 65.74M |
| Abbott Laboratories | 57.73B |
| AngioDynamics, Inc. | 87.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.73M |
| Shareholders Equity (Quarterly) | 10.77M |
| Debt to Equity Ratio | 0.2535 |
| Current Ratio | 0.1203 |
| Net Debt Paydown Yield | 0.39% |